Market revenue in 2022 | USD 76.4 million |
Market revenue in 2030 | USD 912.6 million |
Growth rate | 36.3% (CAGR from 2022 to 2030) |
Largest segment | Deep learning |
Fastest growing segment | Natural language processing |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.77% in 2022. Horizon Databook has segmented the Germany artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
The rising need for innovative medication development to treat the rising prevalence of cancer and other disorders in the region contributes to the market expansion in Germany. Furthermore, research partnerships, collaborations, acquisitions, and mergers with industry participants are expected to boost market expansion.
For instance, in February 2022, the Centers for Personalized Medicine in Germany and Genomic Medicine Sweden joined together to apply precision medicine in healthcare. Under their joint memorandum of understanding, the Centers for Customized Medicine (ZPM) and Genomic Medicine Sweden (GMS) will expand their cooperation.
The MoU states a shared desire to promote precision medicine in a supra-network created and developed by GMS and ZPM on a structural, content-specific, and strategic level. Implementing precision medicine in healthcare with equal access for patients across the nation or area is a shared overall objective of ZPM and GMS.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany artificial intelligence in precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into Germany artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account